Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.
What is new in MS spasticity research? Poster session highlights.
Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
Subgroup analysis in MS trials.
[Progressive multifocal leukoencephalopathy (review)].
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.
Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: A population-based study.
The clinical relevance of force platform measures in multiple sclerosis: a review.
Three-dimensional geometries representing the retinal nerve fiber layer in multiple sclerosis, optic neuritis, and healthy eyes.
Acute bilateral visual loss in a young adult.
Endogenous GABA controls oligodendrocyte lineage cell number, myelination, and CNS internode length.
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Do Not Miss the Eye in Acute Demyelinating Encephalomyelitis.
Elevated HSP27 levels during attacks in patients with multiple sclerosis.
The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
Analysis of prognostic factors associated with longitudinally extensive transverse myelitis.
Linkage of multiple sclerosis and guillain-barre syndrome: a population-based survey in isfahan, iran.
Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells.
Pages
« first
‹ previous
…
351
352
353
354
355
356
357
358
359
…
next ›
last »